Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Maine Rx Negotiations With Manufacturers Continue After Court Ruling

Executive Summary

Maine will delay enrollment for its prescription drug discount program while the state Department of Human Services attempts to reach additional discount agreements with drug manufacturers.
Advertisement

Related Content

Supreme Court Allows Maine Rx; PhRMA Says States Will Delay Similar Plans
Supreme Court Allows Maine Rx; PhRMA Says States Will Delay Similar Plans
PhRMA v. Maine: Supreme Court Suggests HHS Should Review Maine Rx
PhRMA v. Maine: Supreme Court Suggests HHS Should Review Maine Rx
Maine Prior Authorization May Be Rechallenged By PhRMA If Harm Is Shown
Maine Prior Authorization May Be Rechallenged By PhRMA If Harm Is Shown
Vermont Rx Discount Program Expects To Enroll 30% Of Eligibles In 2001
PBM Medicaid Savings To Fund "Tri-State Coalition" Rx Cost-Saving Program
Maine Signs Rx Rebate Deals With 10 Small Firms; SB Stops Shipping To State
Maine Signs Rx Rebate Deals With 10 Small Firms; SB Stops Shipping To State
Advertisement
UsernamePublicRestriction

Register

PS036820

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel